Formulating poly(lactide-co-glycolide) particles for plasmid DNA delivery.

Biodegradable poly(lactide-co-glycolide) (PLGA) particles have shown significant potential for sustained and targeted delivery of several pharmaceutical agents, including plasmid DNA (pDNA). Here, we survey current approaches to PLGA particle preparation for pDNA delivery and discuss recent progress on optimizing formulation development.

[1]  V. Labhasetwar,et al.  Size-dependency of nanoparticle-mediated gene transfection: studies with fractionated nanoparticles. , 2002, International journal of pharmaceutics.

[2]  W. Mark Saltzman,et al.  Synthetic DNA delivery systems , 2000, Nature Biotechnology.

[3]  Wenlei Jiang,et al.  Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens. , 2005, Advanced drug delivery reviews.

[4]  S. Woo,et al.  Viral Vector-Mediated Gene Therapy for Hemophilia B , 1997, Thrombosis and Haemostasis.

[5]  Lei Jiang,et al.  Enhanced immunogenicity of microencapsulated multiepitope DNA vaccine encoding T and B cell epitopes of foot-and-mouth disease virus in mice. , 2006, Vaccine.

[6]  H. Kimoto,et al.  Studies on electrotransfer of DNA into Escherichia coli: effect of molecular form of DNA. , 1996, Biochimica et biophysica acta.

[7]  M. Hashida,et al.  The Fate of Plasmid DNA After Intravenous Injection in Mice: Involvement of Scavenger Receptors in Its Hepatic Uptake , 1995, Pharmaceutical Research.

[8]  H. Merkle,et al.  Hydrophilic poly(DL-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[9]  P. Deluca,et al.  Formulation and in vitro transfection efficiency of poly (D, L-lactideco-glycolide) microspheres containing plasmid DNA for gene delivery , 2000, AAPS PharmSciTech.

[10]  M Marsh,et al.  The structural era of endocytosis. , 1999, Science.

[11]  Qin He,et al.  PELGE nanoparticles as new carriers for the delivery of plasmid DNA. , 2005, Chemical & pharmaceutical bulletin.

[12]  S. Kasturi,et al.  Covalent conjugation of polyethyleneimine on biodegradable microparticles for delivery of plasmid DNA vaccines. , 2005, Biomaterials.

[13]  T. Tsong,et al.  Study of mechanisms of electric field-induced DNA transfection. II. Transfection by low-amplitude, low-frequency alternating electric fields. , 1990, Biophysical journal.

[14]  R. Wattiaux,et al.  Endosomes, lysosomes: their implication in gene transfer. , 2000, Advanced drug delivery reviews.

[15]  T. Kissel,et al.  DNA nano-carriers from biodegradable cationic branched polyesters are formed by a modified solvent displacement method. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[16]  T. Tsong,et al.  Study of mechanisms of electric field-induced DNA transfection. IV. Effects of DNA topology on cell uptake and transfection efficiency. , 1992, Biophysical journal.

[17]  D. Mooney,et al.  Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4) , 2005, Gene Therapy.

[18]  D. Putnam,et al.  PLGA microspheres containing plasmid DNA: preservation of supercoiled DNA via cryopreparation and carbohydrate stabilization. , 1999, Journal of pharmaceutical sciences.

[19]  R. Cristiano,et al.  PEGylated J591 mAb loaded in PLGA-PEG-PLGA tri-block copolymer for targeted delivery: in vitro evaluation in human prostate cancer cells. , 2006, International journal of pharmaceutics.

[20]  M. Alonso,et al.  PLGA:poloxamer and PLGA:poloxamine blend nanoparticles: new carriers for gene delivery. , 2005, Biomacromolecules.

[21]  H. Junginger,et al.  PLGA–PEI nanoparticles for gene delivery to pulmonary epithelium , 2004, European Journal of Pharmaceutics and Biopharmaceutics.

[22]  T. Park,et al.  Degradation of poly(lactic-co-glycolic acid) microspheres: effect of copolymer composition. , 1995, Biomaterials.

[23]  Y. Capan,et al.  Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[24]  A. Salem,et al.  Conjugation of polyamidoamine dendrimers on biodegradable microparticles for nonviral gene delivery. , 2007, Bioconjugate chemistry.

[25]  M. Shive,et al.  Biodegradation and biocompatibility of PLA and PLGA microspheres , 1997 .

[26]  T. Kissel,et al.  The role of branched polyesters and their modifications in the development of modern drug delivery vehicles. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[27]  Byung-Soo Kim,et al.  Poly(l-lactide-co-glycolide) nanospheres conjugated with a nuclear localization signal for delivery of plasmid DNA , 2007, Journal of drug targeting.

[28]  R. Langer,et al.  Exploring polyethylenimine‐mediated DNA transfection and the proton sponge hypothesis , 2005, The journal of gene medicine.

[29]  H. Merkle,et al.  Microencapsulation of DNA using poly(DL-lactide-co-glycolide): stability issues and release characteristics. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[30]  G. Kwon,et al.  Encapsulation of plasmid DNA in biodegradable poly(D, L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[31]  M. Bally,et al.  Plasmid DNA is protected against ultrasonic cavitation-induced damage when complexed to cationic liposomes. , 1996, Journal of pharmaceutical sciences.

[32]  T. Kopp,et al.  Biodegradable PLGA particles for improved systemic and mucosal treatment of Type I allergy. , 2006, Immunology and allergy clinics of North America.

[33]  Robert J. Levy,et al.  Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery , 1997 .

[34]  S. Kong,et al.  Formation of novel hydrophobic complexes between cationic lipids and plasmid DNA. , 1995, Biochemistry.

[35]  L. Barbu-Tudoran,et al.  Design of Amine-Modified Graft Polyesters for Effective Gene Delivery Using DNA-Loaded Nanoparticles , 2004, Pharmaceutical Research.

[36]  L. Lunsford,et al.  Tissue Distribution and Persistence in Mice of Plasmid DNA Encapsulated in a PLGA-Based Microsphere Delivery Vehicle , 2000, Journal of drug targeting.

[37]  M. Hashida,et al.  Disposition Characteristics of Plasmid DNA in the Single-pass Rat Liver Perfusion System , 1996, Pharmaceutical Research.

[38]  Weiliam Chen,et al.  Sustained release of PEG-g-chitosan complexed DNA from poly(lactide-co-glycolide) , 2005, Journal of biomaterials science. Polymer edition.

[39]  U. Bakowsky,et al.  Preparation and characterization of cationic PLGA nanospheres as DNA carriers. , 2004, Biomaterials.

[40]  R. Mehta,et al.  Peptide containing microspheres from low molecular weight and hydrophilic poly(d,l-lactide-co-glycolide) , 1996 .

[41]  C. Demerlis,et al.  Review of the oral toxicity of polyvinyl alcohol (PVA). , 2003, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[42]  C. Pouton,et al.  Nuclear import of polypeptides, polynucleotides and supramolecular complexes. , 1998, Advanced drug delivery reviews.

[43]  Manmohan J. Singh,et al.  The Effect of CTAB Concentration in Cationic PLG Microparticles on DNA Adsorption and in Vivo Performance , 2003, Pharmaceutical Research.

[44]  R. Proulx,et al.  A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle , 2000, Gene Therapy.

[45]  T. VandenDriessche,et al.  Gene therapy for hemophilia: hopes and hurdles , 1998 .

[46]  Anderson,et al.  Biodegradation and biocompatibility of PLA and PLGA microspheres. , 1997, Advanced drug delivery reviews.

[47]  H. Weintraub,et al.  Expression of transfected DNA depends on DNA topology , 1986, Cell.

[48]  L. Seymour,et al.  Key issues in non-viral gene delivery: Adv Drug Deliv Rev , 1998 .

[49]  S. Schwendeman,et al.  Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide) , 2000, Nature Biotechnology.

[50]  W. Hennink,et al.  Effect of DNA topology on the transfection efficiency of poly((2-dimethylamino)ethyl methacrylate)-plasmid complexes. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[51]  T. Burke,et al.  The Acidic Microclimate in Poly(lactide-co-glycolide) Microspheres Stabilizes Camptothecins , 1999, Pharmaceutical Research.

[52]  L. Seymour,et al.  Key issues in non-viral gene delivery. , 1998, Advanced drug delivery reviews.

[53]  Comparative study of DNA encapsulation into PLGA microparticles using modified double emulsion methods and spray drying techniques , 2005, Journal of microencapsulation.

[54]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[55]  A. Salem,et al.  Potent Antigen-specific Immune Responses Stimulated by Codelivery of CpG ODN and Antigens in Degradable Microparticles , 2007, Journal of immunotherapy.

[56]  Manmohan J. Singh,et al.  Cationic microparticles: A potent delivery system for DNA vaccines. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[57]  Ross R. Muth,et al.  Biodegradable polymers for use in surgery—polyglycolic/poly(actic acid) homo- and copolymers: 1 , 1979 .

[58]  R. Durand,et al.  Poly(D, L‐lactide‐co‐glycolide)/poly(ethylenimine) blend matrix system for pH sensitive drug delivery , 2006 .

[59]  R. Levy,et al.  Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles , 2000, Gene Therapy.

[60]  Y. Ikada,et al.  Phagocytosis of polymer microspheres by macrophages , 1990 .

[61]  David Putnam,et al.  Polymers for gene delivery across length scales , 2006, Nature materials.

[62]  Y. Hsu,et al.  Comparison of process parameters for microencapsulation of plasmid DNA in poly(D,L-lactic-co-glycolic) acid microspheres. , 1999, Journal of drug targeting.

[63]  P. Weston,et al.  Transfection of HEK Cells via DNA-loaded PLGA and P(FASA) Nanospheres , 2002, Journal of drug targeting.

[64]  D. Treco,et al.  Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A. , 2001, The New England journal of medicine.

[65]  Zhirong Zhang,et al.  Preparation and characteristics of DNA-nanoparticles targeting to hepatocarcinoma cells. , 2004, World journal of gastroenterology.

[66]  Indu Bala,et al.  PLGA nanoparticles in drug delivery: the state of the art. , 2004, Critical reviews in therapeutic drug carrier systems.

[67]  Y. Waeckerle‐Men,et al.  PLGA microspheres for improved antigen delivery to dendritic cells as cellular vaccines. , 2005, Advanced drug delivery reviews.

[68]  A. Salem,et al.  A comparative study of the antigen-specific immune response induced by co-delivery of CpG ODN and antigen using fusion molecules or biodegradable microparticles. , 2007, Journal of pharmaceutical sciences.

[69]  W. Mark Saltzman,et al.  Controlled DNA Delivery Systems , 1999, Pharmaceutical Research.

[70]  G. Farrar,et al.  Formulation of poly(D,L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[71]  S. Goldstein,et al.  Gene transfection using biodegradable nanospheres: results in tissue culture and a rat osteotomy model , 1999 .

[72]  O. Corrigan,et al.  Comparison of post‐emulsification freeze drying or spray drying processes for the microencapsulation of plasmid DNA , 2005, The Journal of pharmacy and pharmacology.

[73]  A. M. Reed,et al.  Biodegradable polymers for use in surgery — poly(glycolic)/poly(Iactic acid) homo and copolymers: 2. In vitro degradation , 1981 .

[74]  A. Salem,et al.  Comparative study of poly (lactic-co-glycolic acid)-poly ethyleneimine-plasmid DNA microparticles prepared using double emulsion methods , 2008, Journal of microencapsulation.

[75]  C. Tros de Ilarduya,et al.  Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[76]  D. Geddes,et al.  Poly (D, L-lactide-co-glycolide)/DNA microspheres to facilitate prolonged transgene expression in airway epithelium in vitro, ex vivo and in vivo , 2003, Gene Therapy.

[77]  I. Oh,et al.  Physicochemical characterization of poly(L-lactic acid) and poly(D,L-lactide-co-glycolide) nanoparticles with polyethylenimine as gene delivery carrier. , 2005, International journal of pharmaceutics.

[78]  Jayanth Panyam,et al.  Rapid endo‐lysosomal escape of poly(DL‐lactide‐coglycolide) nanoparticles: implications for drug and gene delivery , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[79]  Hans P Merkle,et al.  Formulation aspects of biodegradable polymeric microspheres for antigen delivery. , 2005, Advanced drug delivery reviews.

[80]  D. Bourissou,et al.  Controlled Ring-Opening Polymerization of Lactide and Glycolide , 2005 .

[81]  K. Yip,et al.  Controlled release of plasmid DNA , 1997 .

[82]  Yoshiaki,et al.  Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. , 1999, International journal of pharmaceutics.

[83]  L. Barbu-Tudoran,et al.  Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccination. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[84]  Jayanth Panyam,et al.  Biodegradable nanoparticles for drug and gene delivery to cells and tissue. , 2003, Advanced drug delivery reviews.

[85]  Yoshiaki,et al.  Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with D, L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior. , 1993 .

[86]  M. Marsh,et al.  Cell biology - The structural era of endocytosis , 1999 .

[87]  T. Lindahl,et al.  Rate of depurination of native deoxyribonucleic acid. , 1972, Biochemistry.

[88]  D. Danino,et al.  Poly(D,L-lactide-co-glycolide acid) nanoparticles for DNA delivery: waiving preparation complexity and increasing efficiency. , 2007, Biopolymers.

[89]  Y. Capan,et al.  Preparation and Characterization of Poly (D,L-Lactide-Co-Glycolide) Microspheres for Controlled Release of Poly(L-Lysine) Complexed Plasmid DNA , 1999, Pharmaceutical Research.

[90]  C. Zou,et al.  High efficient encapsulation of plasmid DNA in PLGA microparticles by organic phase self-emulsification. , 2002, Journal of biochemical and biophysical methods.

[91]  R. Mulligan,et al.  Plasmid DNA encapsulation and release from solvent diffusion nanospheres. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[92]  I. Khalil,et al.  Uptake Pathways and Subsequent Intracellular Trafficking in Nonviral Gene Delivery , 2006, Pharmacological Reviews.

[93]  Yoshiaki,et al.  Influence of the Degrees of Hydrolyzation and Polymerization of Poly(vinylalchol)on the Preparation and Properties of Poly(DL-lactide-co-glycolide)nanoparticle. , 1997 .

[94]  Lonnie D Shea,et al.  Design of modular non-viral gene therapy vectors. , 2006, Biomaterials.

[95]  V. Labhasetwar,et al.  Critical Determinants in PLGA/PLA Nanoparticle-Mediated Gene Expression , 2004, Pharmaceutical Research.

[96]  E. Hersh,et al.  Cationic lipid-mediated gene transfer: current concepts. , 1999, Current opinion in molecular therapeutics.

[97]  L. Kwak,et al.  Prophylactic anti-tumor effects in a B cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[98]  M. Hedley.  Formulations containing poly(lactide-co-glycolide) and plasmid DNA expression vectors , 2003, Expert opinion on biological therapy.

[99]  Yi Guo,et al.  Preparation and Evaluation of 5-FU/PLGA/Gene Nanoparticles , 2005 .

[100]  D. Bergstrom,et al.  dsDNA stability dependence on pH and salt concentration. , 1998, BioTechniques.

[101]  P. Giangrande.  Gene therapy for hemophilia? No , 2004, Journal of thrombosis and haemostasis : JTH.